Bill & Melinda Gates FoundationGlobal Grand Challenges
  • Grant Opportunities
  • Challenges
  • Awards
  • Champions
  • Partnerships
  • News
  • About

Drugs That Invert Selection for Resistance

Roy Kishony of Harvard University will seek to identify chemical entities that act as "selection inverters" which actively target antibiotic-resistant bacteria. Selection- inverters could be used in combination with traditional antibiotics to prevent resistance and possibly even drive a drug-resistant bacteria population back to drug sensitivity.

More information about Create Drugs and Delivery Systems to Limit Drug Resistance (Round 1)